Braun-Bostich & Associates’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $929K | Sell |
4,350
-3
| -0.1% | -$671 | 0.58% | 42 |
|
|
2025
Q4 | $745K | Sell |
4,353
-1
| -0% | -$156 | 0.46% | 49 |
|
|
2025
Q3 | $583K | Buy |
4,354
+23
| +0.5% | +$2.44K | 0.37% | 54 |
|
|
2025
Q2 | $422K | Sell |
4,331
-7
| -0.2% | -$555 | 0.29% | 66 |
|
|
2025
Q1 | $315K | Buy |
4,338
+85
| +2% | +$6.69K | 0.23% | 79 |
|
|
2024
Q4 | $307K | Buy |
4,253
+33
| +0.8% | +$2.5K | 0.22% | 76 |
|
|
2024
Q3 | $344K | Sell |
4,220
-40
| -0.9% | -$3.48K | 0.24% | 72 |
|
|
2024
Q2 | $454K | Sell |
4,260
-10
| -0.2% | -$959 | 0.34% | 59 |
|
|
2024
Q1 | $415K | Sell |
4,270
-1,000
| -19% | -$88K | 0.35% | 74 |
|
|
2023
Q4 | $413K | Buy |
+5,270
| New | +$359K | 0.37% | 67 |
|
|
2023
Q3 | – | Sell |
-5,430
| Closed | -$349K | – | 81 |
|
|
2023
Q2 | $349K | Buy |
5,430
+50
| +0.9% | +$2.82K | 0.75% | 50 |
|
|
2023
Q1 | $285K | Buy |
5,380
+140
| +3% | +$6.87K | 0.67% | 50 |
|
|
2022
Q4 | $220K | Sell |
5,240
-760
| -13% | -$31.8K | 0.64% | 55 |
|
|
2022
Q3 | $220K | Buy |
6,000
+50
| +0.8% | +$2.23K | 0.67% | 53 |
|
|
2022
Q2 | $254K | Buy |
5,950
+870
| +17% | +$41.4K | 0.66% | 53 |
|
|
2022
Q1 | $273K | Buy |
5,080
+810
| +19% | +$47.2K | 0.59% | 57 |
|
|
2021
Q4 | $283K | Sell |
4,270
-750
| -15% | -$47K | 0.07% | 87 |
|
|
2021
Q3 | $286K | Hold |
5,020
| – | – | 0.54% | 51 |
|
|
2021
Q2 | $327K | Hold |
5,020
| – | – | 0.6% | 45 |
|
|
2021
Q1 | $299K | Sell |
5,020
-370
| -7% | -$20.2K | 0.57% | 47 |
|
|
2020
Q4 | $255K | Hold |
5,390
| – | – | 0.51% | 50 |
|
|
2020
Q3 | $179K | Sell |
5,390
-5,930
| -52% | -$204K | 0.18% | 98 |
|
|
2020
Q2 | $366K | Hold |
11,320
| – | – | 0.36% | 51 |
|
|
2020
Q1 | $253K | Hold |
11,320
| – | – | 0.32% | 64 |
|
|
2019
Q4 | $337K | Sell |
11,320
-2,740
| -19% | -$72.8K | 0.33% | 62 |
|
|
2019
Q3 | $325K | Sell |
14,060
-3,980
| -22% | -$83.6K | 0.38% | 63 |
|
|
2019
Q2 | $339K | Sell |
18,040
-17,240
| -49% | -$327K | 0.35% | 54 |
|
|
2019
Q1 | $632K | Sell |
35,280
-8,870
| -20% | -$148K | 0.66% | 32 |
|
|
2018
Q4 | $601K | Buy |
44,150
+9,190
| +26% | +$132K | 0.64% | 49 |
|
|
2018
Q3 | $530K | Buy |
34,960
+1,160
| +3% | +$19.8K | 0.51% | 68 |
|
|
2018
Q2 | $584K | Sell |
33,800
-320
| -0.9% | -$6.16K | 0.58% | 57 |
|
|
2018
Q1 | $693K | Buy |
34,120
+2,310
| +7% | +$45.8K | 0.6% | 52 |
|
|
2017
Q4 | $586K | Buy |
+31,810
| New | +$625K | 0.5% | 64 |
|
Other funds holding LRCX
VCM
VPM
Braun-Bostich & Associates's LRCX Position: Q1 2026 in Review
Braun-Bostich & Associates reduced its Lam Research (LRCX) stake by 0.07% in Q1 2026, selling an estimated $671 and leaving 4,350 shares worth $929K. The position accounts for 0.58% of the portfolio, ranked #42.
Braun-Bostich & Associates first reported a position in LRCX in Q4 2017 and has held it in 33 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.
- Braun-Bostich & Associates held 4,350 shares of Lam Research worth $929K as of Q1 2026.
- Braun-Bostich & Associates sold 3 Lam Research shares in Q1 2026, an estimated $671.
- Lam Research made up 0.58% of Braun-Bostich & Associates's portfolio in Q1 2026, its #42 holding.
- Braun-Bostich & Associates first reported a position in Lam Research in Q4 2017 and has held it in 33 quarters since.
- 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.
Based on Braun-Bostich & Associates's 13F filing for Q1 2026, filed 15 Apr 2026.